CYP26B1 and hepatocellular carcinoma: A portion of these DEGs also possessed the potential to serve as prognostic indicators to predict the survival outcome of HCCs with mutational signatures, such as the high levels of expression of CPSF6, LOC151174, CYP26B1, and GPR83 were associated with poor patient outcomes of HCC patients.